What is Corcept Therapeutics's free cash flow?

Corcept Therapeutics (CORT) reported free cash flow of -$16.97M in Q1 2026.

How has Corcept Therapeutics's free cash flow changed year-over-year?

Corcept Therapeutics's free cash flow decreased by 463.8% year-over-year, from $4.67M to -$16.97M.

What is the long-term trend for Corcept Therapeutics's free cash flow?

Over 4 years (2021 to 2025), Corcept Therapeutics's free cash flow has grown at a -4.1% compound annual growth rate (CAGR), from $167.42M to $141.79M.

Corcept Therapeutics CORT Free cash flow

Free cash flow at other companies

Regeneron PharmaceuticalsREGN

$848.3M+4.0%

ExelixisEXEL

——

CytokineticsCYTK

——

Praxis Precision Medicines, Inc.PRAX

——

IncyteINCY

——

Summit TherapeuticsSMMT

——

Other financials

Income statement

See full

Revenue$164.9M+4.9%

Gross profit$162.0M+4.7%

Operating income-$49.6M-1,552%

Net income-$31.8M-255%

EPS (diluted)-$0.30-276%

Balance sheet

See full

Cash & equivalents$110.0M+21.1%

Total debt$9.6M+41.0%

Total equity$638.0M-6.6%

Total assets$814.9M-3.7%

Cash flow

See full

Operating cash flow-$16.8M-452%

CapEx$201.0K+93.3%

Valuation

See full

Market cap$8.58B-64.4%

Enterprise value$8.48B-65.0%

P/E181.2×+1.3×

P/S11.2×-24.0×

Profitability

See full

Gross margin98.3%-0.2pp

Operating margin-1.1%-17.2pp

Net margin6.2%-13.4pp

FCF margin15.6%-10.2pp

Returns & leverage

See full

Return on equity7.2%-14.6pp

Debt / equity0×0.0×

Current ratio2.9×-0.2×

Where this comes from

Calculated from Corcept Therapeutics’s reported figures.

−$16.8Mnet cash from operating−$201.0Kcapital expenditures=-$16.97M

The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corcept Therapeutics's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corcept Therapeutics's free cash flow?: Corcept Therapeutics (CORT) reported free cash flow of -$16.97M in Q1 2026.
How has Corcept Therapeutics's free cash flow changed year-over-year?: Corcept Therapeutics's free cash flow decreased by 463.8% year-over-year, from $4.67M to -$16.97M.
What is the long-term trend for Corcept Therapeutics's free cash flow?: Over 4 years (2021 to 2025), Corcept Therapeutics's free cash flow has grown at a -4.1% compound annual growth rate (CAGR), from $167.42M to $141.79M.